|本期目录/Table of Contents|

[1]连宇航,余胡燕,田志霞,等.高尿酸血症对特发性膜性肾病患者肾小管萎缩/间质纤维化的预测价值[J].天津医科大学学报,2022,28(04):403-408,427.
　LIAN Yu-Hang,YU Hu-Yan,TIAN Zhi-Xia,et al.Predictive value of hyperuricemia on tubular atrophy/interstitial fibrosis in patients with idiopathic membranous nephropathy[J].Journal of Tianjin Medical University,2022,28(04):403-408,427.
点击复制

高尿酸血症对特发性膜性肾病患者肾小管萎缩/间质纤维化的预测价值(PDF)
分享到：

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:
28卷
期数:
2022年04期
页码:
403-408,427
栏目:
临床医学
出版日期:
2022-07-20

文章信息/Info

Title:
Predictive value of hyperuricemia on tubular atrophy/interstitial fibrosis in patients with idiopathic membranous nephropathy
文章编号:
1006-8147（2022）04-0403-07
作者:
连宇航1; 余胡燕2; 田志霞1; 闫铁昆3; 李栋3
（1.天津医科大学研究生院，天津300070；2.广东省浮云市人民医院肾内科，广东523146；3.天津医科大学总医院肾内科，天津300052）
Author(s):
LIAN Yu-Hang1; YU Hu-Yan2; TIAN Zhi-Xia1; YAN Tie-Kun3; LI Dong3
（1.Graduate school，Tianjin Medical University，Tianjin 300070，China；2.Department of Nephrology，Guangdong Fuyun People′s Hospital，Guangdong 523146，China；3.Department of Nephrology，General Hospital，Tianjin Medical University，Tianjin 300052，China）
关键词:
高尿酸血症; 特发性膜性肾病; 肾小管萎缩/间质纤维化; 预测价值
Keywords:
hyperuricemia; Idiopathic membranous nephropathy; renal tubular atrophy / interstitial fibrosis; predictive value
分类号:
R781.4
DOI:
-
文献标志码:
A
摘要:
目的：探讨尿酸（UA）与特发性膜性肾病（IMN）患者肾小管萎缩/间质纤维化（TA/IF）之间的关系及预测价值。方法：本研究纳入2018—2021年在天津医科大学总医院经肾活检证实的390例IMN患者。收集肾活检时的各项临床参数。根据肾穿刺活检前的UA值将患者分为正常尿酸组（normal-UA group，N-UA组，n=229）、高尿酸组（high-UA group，H-UA组，n=161）。根据TA/IF的程度，将患者分为T1组（无/轻度，n=154）、T2组（中度，n=167）、T3组（重度，n=69）。通过单因素和多因素Logistic回归对TA/IF程度的影响因素进行分析。采用受试者工作特征（ROC）曲线分析 UA 对TA/IF程度的预测价值。结果：与N-UA组相比，H-UA组中重度TA/IF的比例明显较高 （χ2 =84.352，P＜0.000），评估的肾小球滤过率（eGFR）显著降低（t=2.532，P=0.012）。UA 水平为中重度TA/IF的独立危险因素[OR=1.026（95%CI：1.021~1.031），OR=1.036（95%CI：1.030~1.042），P＜0.000]。模型4（HUA+血清球蛋白+24 h尿蛋白）的曲线下面积（AUC）大于其他3个模型。结论：合理控制UA可能减少中重度TA/IF发生的风险。
Abstract:
Objective： To investigate the relationship and predictive value between uric acid （UA） and renal tubular atrophy / interstitial fibrosis （TA/IF） in patients with idiopathic membranous Nephropathy （IMN）. Methods： The present study enrolled 390 patients with IMN confirmed by renal biopsy in the General Hospital of Tianjin Medical University from 2018 to 2021. The clinical parameters of renal biopsy were collected. According to the UA value before renal biopsy，the patients were divided into normal UA group（N-UA，n=229） and high UA group（H-UA，n=161）. According to the degree of TA/IF，the patients were divided into T1 group（n=154），T2 group（n=167） and T3 group（n=69）. Univariate and multivariate Logistic regression for factors influencing extent of TA/IF was analyzed. Receiver operating characteristic（ROC） curve was used to analyze the predictive value of UA on the degree of TA/IF. Results： Compared with N-UA group，the proportion of moderate and severe TA/IF was significantly higher in H-UA group（χ2 =84.352，P＜0.000），and the evaluated glomerular filtration rate（eGFR） was significantly lower（t=2.532，P=0.012）. UA level was an independent risk factor for moderate and severe TA/IF [OR=1.026 （95%CI：1.021-1.031），OR=1.036（95%CI：1.030-1.042），P＜0.000]. The area under the curve （AUC） of model 4（HUA+Glb+24 h urinary protein） was greater than that of the other three models. Conclusion: Reasonable control of UA may reduce the risk of moderate and severe TA/IF to some extent.

参考文献/References:

[1] HAYASHI N，OKADA K，MATSUI Y，et al. Glomerular mannose-binding lectin deposition in intrinsic antigen-related membranous nephropathy[J]. Nephrol Dial Transplant，2018，33（5）：832-840.
[2] HORVATIC I，LJUBANOVIC D G，BULIMBASIC S，et al. Prognostic significance of glomerular and tubulointerstitial morphometry in idiopathic membranous nephropathy[J]. Pathol Res Pract，2012， 208（11）：662-667.
[3] RUGGENENTI P，CHIURCHIU C，ABBATE M，et al. Rituximab for idiopathic membranous nephropathy： who can benefit?[J]. Clin J Am Soc Nephrol 2006，1（4）：738-748.
[4] STANGOU M J，MARINAKI S，PAPACHRISTOU E，et al. Histological grading in primary membranous nephropathy is essential for clinical management and predicts outcome of patients[J]. Histopathology，2019，75（5）：660-671.
[5] PONTICELLI C，PODESTA M A，MORONI G. Hyperuricemia as a trigger of immune response in hypertension and chronic kidney disease[J]. Kidney Int，2020，98（5）：1149-1159.
[6] SETHI S，HAAS M，MARKOWITZ G S，et al. Mayo clinic/renal pathology society consensus report on pathologic classification，diagnosis，and reporting of GN[J]. J Am Soc Nephrol，2016，27（5）：1278-1287.
[7] XIAOFAN H，JING X，CHENNI G，et al. New risk score for predicting progression of membranous nephropathy[J]. J Transl Med，2019，17（1）：41.
[8] SEGAL P E，CHOI M J. Recent advances and prognosis in idiopathic membranous nephropathy[J]. Adv Chronic Kidney Dis，2012，19（2）：114-119.
[9] ZEISBERG M，NEILSON E G. Mechanisms of tubulointerstitial fibrosis[J]. J Am Soc Nephrol，2010，21（11）：1819-1834.
[10] WU Q，JINDE K，NISHINA M，et al. Analysis of prognostic predictors in idiopathic membranous nephropathy[J]. Am J Kidney Dis，2001，37（2）：380-387.
[11] PARASKEVAKOU H，KAVANTZAS N，PAVLOPOULOS P M，et al. Membranous glomerulonephritis： a morphometric study[J]. Pathol Res Pract，2000，196（3）：141-144.
[12] MIGUEL V，RAMOS R，GARCIA-BERMEJO L，et al. The program of renal fibrogenesis is controlled by microRNAs regulating oxidative etabolism[J]. Redox Biol，2021，40：101851.
[13] KIM I Y，LEE D W，LEE S B，et al. The role of uric acid in kidney fibrosis：experimental evidences for the causal relationship[J]. Biomed Res Int，2014，2014：638732.
[14] WORAWICHAWONG S，WORAWICHAWONG S，RADINAHAMED P，et al. Urine epidermal growth factor，monocyte chemoattractant protein-1 or their ratio as biomarkers for interstitial fibrosis and tubular atrophy in primary glomerulonephritis[J]. Kidney Blood Press Res，2016，41（6）：997-1007.
[15] ZHANG J，PAN M，ZHANG J，et al. Serum uric acid is an independent predictor of renal outcomes in patients with idiopathic membranous nephropathy[J]. Int Urol Nephrol，2019，51（10）：1797-1804.
[16] PONTICELLI C，PODESTA M A，MORONI G. Hyperuricemia as a trigger of immune response in hypertension and chronic kidney disease[J]. Kidney Int，2020，98（5）：1149-1159.
[17] KIM I Y，LEE D W，LEE S B，et al. The role of uric acid in kidney fibrosis：experimental evidences for the causal relationship[J]. Biomed Res Int，2014，2014：638732.

相似文献/References:

[1]苏东峰,聂秀玲,孙丽荣.2型糖尿病合并高尿酸血症临床特征及相关危险因素分析[J].天津医科大学学报,2013,19(06):481.
[2]郭彩云,聂秀玲,孙丽荣,等.高尿酸血症/痛风与非酒精性脂肪肝严重程度的相关研究[J].天津医科大学学报,2013,19(06):499.
　GUO Cai-yun,NIE Xiu-ling,SUN Li-rong,et al.Hyperuricemia or gout associated with the severity of nonalcoholic fatty liver disease[J].Journal of Tianjin Medical University,2013,19(04):499.
[3]薛志杰综述,王荔,杨虎,等.特发性膜性肾病的临床治疗进展[J].天津医科大学学报,2022,28(03):336.

备注/Memo

备注/Memo:
作者简介:连宇航(1996-)，女，硕士在读，研究方向：肾病学；通信作者：李栋：E-mail：lidong430@126.com。
更新日期/Last Update: 2022-07-20